Azamulin

Azamulin is a pleuromutilin antibiotic.[1] As of 2016, it is not marketed in the US or Europe.

Azamulin
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC24H38N4O4S
Molar mass478.65 g·mol−1
3D model (JSmol)

In pharmacological studies, the substance is used as an inhibitor of the liver enzymes CYP3A4 and CYP3A5.[2][3]

References

  1. Stresser, D. M.; Broudy, M. I.; Ho, T; Cargill, C. E.; Blanchard, A. P.; Sharma, R; Dandeneau, A. A.; Goodwin, J. J.; Turner, S. D.; Erve, J. C.; Patten, C. J.; Dehal, S. S.; Crespi, C. L. (2004). "Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible". Drug Metabolism and Disposition. 32 (1): 105–12. doi:10.1124/dmd.32.1.105. PMID 14709627.
  2. Ghosal, A; Ramanathan, R; Yuan, Y; Hapangama, N; Chowdhury, S. K.; Kishnani, N. S.; Alton, K. B. (2007). "Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist". Drug Metabolism and Disposition. 35 (12): 2186–95. doi:10.1124/dmd.107.017517. PMID 17827338.
  3. Mitra, R; Goodman Jr, O. B. (2015). "CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR". The Prostate. 75 (5): 527–38. doi:10.1002/pros.22940. PMID 25586052.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.